Loading...

CONMED Corporation Peer Comparison

Metric Value Ranking
Market Cap $1.9 Billion 8/17 STE
$21.5B
GMED
$11.4B
GKOS
$7.9B
ITGR
$4.6B
IRTC
$3.5B
LIVN
$2.6B
NUVA
$2.1B
CNMD
$1.9B
ATEC
$1.5B
HSKA
$1.3B
OFIX
$690.1M
SIBN
$680.2M
KIDS
$603.2M
SRDX
$483.9M
LUNG
$276.8M
ANIK
$257.9M
SGHT
$129.9M
Gross Margin 57% 12/17 ATEC
100%
SGHT
84%
SIBN
79%
GKOS
77%
SRDX
75%
LUNG
74%
KIDS
73%
NUVA
72%
LIVN
71%
IRTC
69%
OFIX
69%
CNMD
57%
GMED
57%
STE
44%
HSKA
44%
ITGR
16%
ANIK
4%
Profit Margin 15% 1/17 CNMD
15%
STE
11%
LIVN
10%
GMED
8%
ITGR
5%
NUVA
2%
SRDX
-12%
OFIX
-14%
KIDS
-15%
HSKA
-16%
SIBN
-16%
GKOS
-22%
IRTC
-31%
SGHT
-55%
LUNG
-69%
ANIK
-77%
ATEC
-83%
EBITDA margin 21% 2/17 LIVN
23%
CNMD
21%
NUVA
19%
STE
17%
GMED
8%
ITGR
8%
SRDX
0%
OFIX
-6%
KIDS
-10%
HSKA
-17%
SIBN
-19%
GKOS
-26%
IRTC
-34%
SGHT
-56%
ANIK
-66%
LUNG
-69%
ATEC
-184%
Quarterly Revenue $316.7 Million 6/17 STE
$1.3B
ITGR
$746.3M
GMED
$625.7M
LIVN
$318.1M
NUVA
$317.8M
CNMD
$316.7M
OFIX
$196.6M
IRTC
$147.5M
GKOS
$96.7M
HSKA
$62.4M
KIDS
$54.6M
ATEC
$48.0M
SIBN
$40.3M
ANIK
$38.8M
SRDX
$29.9M
LUNG
$20.4M
SGHT
$20.2M
Quarterly Earnings $49.0 Million 3/17 STE
$150.0M
GMED
$51.8M
CNMD
$49.0M
ITGR
$35.4M
LIVN
$33.0M
NUVA
$7.4M
SRDX
-$3.7M
SIBN
-$6.6M
KIDS
-$7.9M
HSKA
-$9.8M
SGHT
-$11.1M
LUNG
-$14.1M
GKOS
-$21.4M
OFIX
-$27.4M
ANIK
-$29.9M
ATEC
-$39.6M
IRTC
-$46.2M
Quarterly Free Cash Flow $47.8 Million 4/17 GMED
$161.7M
STE
$148.8M
ITGR
$131.8M
CNMD
$47.8M
LIVN
$32.8M
OFIX
$32.1M
IRTC
$15.5M
ANIK
$3.8M
SGHT
$549,000
NUVA
-$495,000
SIBN
-$2.7M
LUNG
-$7.7M
SRDX
-$8.2M
GKOS
-$11.0M
HSKA
-$11.0M
KIDS
-$11.3M
ATEC
-$17.1M
Trailing 4 Quarters Revenue $1.3 Billion 4/17 STE
$5.4B
GMED
$2.5B
ITGR
$2.0B
CNMD
$1.3B
LIVN
$1.2B
NUVA
$1.2B
OFIX
$784.2M
IRTC
$560.0M
ATEC
$470.0M
GKOS
$360.3M
HSKA
$254.9M
KIDS
$189.7M
ANIK
$164.2M
SIBN
$157.0M
SRDX
$125.4M
SGHT
$79.5M
LUNG
$60.0M
Trailing 4 Quarters Earnings $131.7 Million 2/17 STE
$1.3B
ITGR
$746.3M
GMED
$625.7M
LIVN
$318.1M
NUVA
$317.8M
CNMD
$316.7M
OFIX
$196.6M
IRTC
$147.5M
GKOS
$96.7M
HSKA
$62.4M
KIDS
$54.6M
ATEC
$48.0M
SIBN
$40.3M
ANIK
$38.8M
SRDX
$29.9M
LUNG
$20.4M
SGHT
$20.2M
Quarterly Earnings Growth 209% 4/17 GMED
5094%
NUVA
925%
LIVN
550%
CNMD
209%
SIBN
34%
GKOS
30%
STE
30%
ITGR
30%
SGHT
15%
ATEC
7%
OFIX
5%
LUNG
5%
HSKA
2%
IRTC
-70%
KIDS
-72%
ANIK
-355%
SRDX
-365%
Annual Earnings Growth 131% 2/17 LIVN
737%
CNMD
131%
LUNG
32%
OFIX
19%
ITGR
15%
SIBN
14%
SGHT
12%
ATEC
10%
STE
-11%
GKOS
-16%
GMED
-47%
NUVA
-50%
HSKA
-66%
IRTC
-82%
KIDS
-115%
SRDX
-175%
ANIK
-559%
Quarterly Revenue Growth 4% 10/17 GMED
63%
KIDS
37%
GKOS
24%
SIBN
19%
IRTC
18%
LUNG
15%
LIVN
11%
OFIX
7%
ITGR
6%
CNMD
4%
NUVA
2%
SGHT
1%
STE
-1%
SRDX
-2%
HSKA
-4%
ANIK
-7%
ATEC
-59%
Annual Revenue Growth 2% 12/17 GMED
97%
KIDS
20%
SIBN
17%
GKOS
13%
IRTC
13%
SRDX
10%
LIVN
6%
ITGR
6%
OFIX
5%
NUVA
4%
STE
4%
CNMD
2%
ATEC
0%
HSKA
-5%
ANIK
-6%
SGHT
-12%
LUNG
-13%
Cash On Hand $38.5 Million 13/17 GMED
$622.8M
IRTC
$519.5M
LIVN
$346.4M
STE
$172.2M
HSKA
$125.2M
SGHT
$118.6M
GKOS
$100.1M
ATEC
$81.0M
NUVA
$80.7M
LUNG
$63.3M
ANIK
$62.4M
KIDS
$51.0M
CNMD
$38.5M
ITGR
$35.6M
SIBN
$30.2M
SRDX
$30.1M
OFIX
$30.1M
Short Term Debt $717,000 14/17 NUVA
$360.8M
STE
$80.0M
LIVN
$22.0M
IRTC
$15.5M
ITGR
$13.9M
GMED
$11.0M
ATEC
$8.8M
OFIX
$7.0M
HSKA
$4.0M
ANIK
$2.3M
SIBN
$1.2M
SRDX
$1.0M
LUNG
$762,000
CNMD
$717,000
KIDS
$158,000
GKOS
-$0
SGHT
-$0
Long Term Debt $940.1 Million 3/17 STE
$2.3B
ITGR
$1.2B
CNMD
$940.1M
IRTC
$719.8M
LIVN
$604.3M
ATEC
$555.1M
NUVA
$545.4M
GMED
$523.5M
GKOS
$157.1M
OFIX
$130.2M
HSKA
$105.4M
LUNG
$55.0M
SIBN
$37.3M
SGHT
$34.2M
SRDX
$32.0M
ANIK
$25.2M
KIDS
$24.4M
PE 14.66 6/17 GMED
125.00
LIVN
109.24
NUVA
73.28
STE
49.51
ITGR
40.57
CNMD
14.66
GKOS
-1.00
IRTC
-1.00
HSKA
-1.00
SRDX
-1.00
OFIX
-1.00
KIDS
-1.00
ANIK
-1.00
ATEC
-1.00
SIBN
-1.00
LUNG
-1.00
SGHT
-1.00
PS 1.50 16/17 GKOS
21.98
IRTC
6.21
HSKA
5.14
GMED
4.62
LUNG
4.61
SIBN
4.33
STE
3.97
SRDX
3.86
ATEC
3.22
KIDS
3.18
ITGR
2.29
LIVN
2.08
NUVA
1.70
SGHT
1.63
ANIK
1.57
CNMD
1.50
OFIX
0.88
PB 2.07 11/17 IRTC
48.48
GKOS
11.85
SRDX
4.33
SIBN
4.12
STE
3.26
HSKA
3.14
LUNG
2.95
ITGR
2.84
GMED
2.81
NUVA
2.34
CNMD
2.07
LIVN
1.98
KIDS
1.63
ANIK
1.43
SGHT
1.37
OFIX
1.31
ATEC
0.00
PC 50.19 4/17 ITGR
129.50
STE
125.02
GKOS
79.09
CNMD
50.19
NUVA
25.83
OFIX
22.96
SIBN
22.51
ATEC
18.70
GMED
18.37
SRDX
16.05
KIDS
11.82
HSKA
10.46
LIVN
7.47
IRTC
6.70
LUNG
4.37
ANIK
4.14
SGHT
1.10
Liabilities to Equity 1.48 2/17 IRTC
11.68
CNMD
1.48
NUVA
1.34
ITGR
0.95
LIVN
0.93
LUNG
0.78
OFIX
0.65
STE
0.55
SGHT
0.51
SRDX
0.46
HSKA
0.42
GKOS
0.39
SIBN
0.38
KIDS
0.32
ANIK
0.29
GMED
0.25
ATEC
0.00
ROA 0.06 1/17 CNMD
6%
STE
4%
ITGR
4%
GMED
2%
LIVN
1%
NUVA
1%
HSKA
-3%
KIDS
-6%
SRDX
-9%
OFIX
-14%
GKOS
-16%
SIBN
-16%
IRTC
-17%
ATEC
-24%
LUNG
-26%
SGHT
-35%
ANIK
-42%
ROE 0.14 2/17 ATEC
13059%
CNMD
14%
STE
7%
ITGR
7%
NUVA
3%
LIVN
2%
GMED
2%
HSKA
-5%
KIDS
-8%
SRDX
-13%
GKOS
-22%
OFIX
-23%
SIBN
-23%
LUNG
-46%
SGHT
-53%
ANIK
-54%
IRTC
-210%
Current Ratio 1.67 15/17 GMED
5.00
ANIK
4.49
KIDS
4.13
SIBN
3.66
GKOS
3.59
HSKA
3.39
SRDX
3.15
SGHT
2.95
STE
2.82
OFIX
2.54
LUNG
2.28
LIVN
2.08
ITGR
2.05
NUVA
1.75
CNMD
1.67
IRTC
1.09
ATEC
1.00
Quick Ratio 0.03 16/17 GMED
125.00
LIVN
109.24
NUVA
73.28
STE
49.51
ITGR
40.57
CNMD
14.66
GKOS
-1.00
IRTC
-1.00
HSKA
-1.00
SRDX
-1.00
OFIX
-1.00
KIDS
-1.00
ANIK
-1.00
ATEC
-1.00
SIBN
-1.00
LUNG
-1.00
SGHT
-1.00
Long Term Debt to Equity 1.01 2/17 IRTC}
10.03
CNMD}
1.01
ITGR}
0.71
NUVA}
0.61
LUNG}
0.59
LIVN}
0.46
SGHT}
0.36
STE}
0.35
SRDX}
0.29
HSKA}
0.25
OFIX}
0.25
GKOS}
0.24
SIBN}
0.23
ANIK}
0.14
GMED}
0.13
KIDS}
0.07
ATEC}
-407.54
Debt to Equity 1.01 3/17 IRTC
10.25
NUVA
1.02
CNMD
1.01
ITGR
0.72
LUNG
0.59
LIVN
0.48
STE
0.36
SGHT
0.36
SRDX
0.30
HSKA
0.26
OFIX
0.26
GKOS
0.24
SIBN
0.23
GMED
0.13
KIDS
0.07
ANIK
0.01
ATEC
-413.99
Burn Rate -3.43 14/17 SGHT
9.54
HSKA
8.35
IRTC
6.59
SRDX
5.81
KIDS
5.71
LUNG
3.83
GKOS
3.62
SIBN
3.61
ITGR
2.48
ANIK
1.98
ATEC
1.26
OFIX
0.88
NUVA
0.77
CNMD
-3.43
STE
-4.48
GMED
-22.13
LIVN
-105.16
Cash to Cap 0.02 14/17 SGHT
0.91
ANIK
0.24
LUNG
0.23
IRTC
0.15
LIVN
0.13
HSKA
0.10
KIDS
0.08
SRDX
0.06
GMED
0.05
ATEC
0.05
NUVA
0.04
OFIX
0.04
SIBN
0.04
CNMD
0.02
GKOS
0.01
STE
0.01
ITGR
0.01
CCR 0.98 8/17 ITGR
3.72
GMED
3.12
SRDX
2.24
KIDS
1.43
HSKA
1.13
LIVN
1.00
STE
0.99
CNMD
0.98
LUNG
0.54
GKOS
0.52
ATEC
0.43
SIBN
0.42
SGHT
-0.05
NUVA
-0.07
ANIK
-0.13
IRTC
-0.34
OFIX
-1.17
EV to EBITDA 43.12 6/17 SRDX}
23181.03
GMED}
236.00
STE}
108.00
ITGR}
98.99
NUVA}
47.54
CNMD}
43.12
LIVN}
39.04
SGHT}
-4.05
ANIK}
-7.74
LUNG}
-19.06
ATEC}
-22.58
OFIX}
-64.42
IRTC}
-73.46
SIBN}
-90.21
KIDS}
-103.62
HSKA}
-124.13
GKOS}
-323.48
EV to Revenue 2.20 14/17 GKOS
22.14
IRTC
6.60
HSKA
5.08
GMED
4.58
LUNG
4.49
SIBN
4.38
STE
4.37
ATEC
4.25
SRDX
3.88
KIDS
3.04
ITGR
2.86
NUVA
2.37
LIVN
2.31
CNMD
2.20
ANIK
1.21
OFIX
1.02
SGHT
0.57